...
首页> 外文期刊>ACS medicinal chemistry letters >Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design
【24h】

Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design

机译:PI3Kα与PI103及其衍生物复合的晶体结构:抑制剂设计的新方向

获取原文
获取原文并翻译 | 示例
           

摘要

The phosphatidylinositol 3-kinase (PI3K) signaling pathway plays important roles in cell proliferation, growth, and survival. Hyperactivated PI3K is frequently found in a wide variety of human cancers, validating it as a promising target for cancer therapy. We determined the crystal structure of the human PI3Kα-PI103 complex to unravel molecular interactions. Based on the structure, substitution at the R1 position of the phenol portion of PI103 was demonstrated to improve binding affinity via forming a new H-bond with Lys802 at the bottom of the ATP catalytic site. Interestingly, the crystal structure of the PI3Kα-9d complex revealed that the flexibility of Lys802 can also induce additional space at the catalytic site for further modification. Thus, these crystal structures provide a molecular basis for the strong and specific interactions and demonstrate the important role of Lys802 in the design of novel PI3Kα inhibitors.
机译:磷脂酰肌醇3-激酶(PI3K)信号通路在细胞增殖,生长和存活中起重要作用。高活化的PI3K经常在各种人类癌症中发现,使其成为癌症治疗的有希望的靶标。我们确定了人类PI3Kα-PI103复合物的晶体结构,以揭示分子相互作用。基于该结构,证明了通过在ATP催化位点的底部与Lys802形成新的H键,PI103的酚部分的R1位置的取代可提高结合亲和力。有趣的是,PI3Kα-9d配合物的晶体结构表明,Lys802的柔韧性还可以在催化位点诱导额外的空间,以便进一步修饰。因此,这些晶体结构为强而特异性的相互作用提供了分子基础,并证明了Lys802在新型PI3Kα抑制剂设计中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号